Timeline
BrainChild project builds precision cancer treatment platform for children in Sweden
Google warns quantum computers threaten current encryption systems
Novo Nordisk's terrible week reveals the brutal economics of the obesity drug gold rush
A week in biotech: Four IPOs launch in a single week as Eli Lilly breaks the trillion-dollar barrier
Google.org launches $30m AI for Science challenge
NVIDIA survey finds healthcare AI moving from pilots to production with measurable returns
Injecting mitochondria from the young into the old
Google-backed Isomorphic Labs to start human trials for AI Drugs
Ancient Babylonian text deciphered with AI
Google DeepMind launches DNA predicting AI model, AlphaGenome
Hims & Hers hit as Novo Nordisk withdraws weightloss drugs
British rocket scientists 'going rogue' to test plasma propulsion this weekend
23andMe to face legal showdown over DNA data sale
NASA and SpaceX successfully launch new international space mission
Jellyfish protein finger-print dye promises sustainability boost to forensics
Viagra can reduce Alzheimer's risk, new study claims
Protect the Moon! Astronomers call for preservation as lunar industry is set to boom
Child's giant discovery confirmed by UK scientists
Ozempic and other drugs targeted in US regulator's patent clampdown
Ozempic and Wegovy demand drives another record quarter for Novo Nordisk
Eta Aquariid meteor shower: Wish on a shooting star this weekend
Novavax stock price doubles on deal with Sanofi for COVID and flu shots
Hims & Hers stock rockets as says it will sell Ozempic-like weight loss drugs
Brits desperately searching for Ozempic
Ozempic study shows it can slow kidney disease
Moderna shares up as investors eye US funding for bird flu trials
Psychedelic stocks hit after FDA advisors snub MDMA treatment for PTSD
Eli Lilly and OpenAI team up to fight drug-resistant bacteria
SpaceX was valued at $210bn as it lands $843mln ISS contract
Novo Nordisk shares slipped after researchers boosted Eli Lilly’s weight loss drugs
BP warns energy transition is at risk of being ‘disorderly’ and more costly, says global demand is still rising
Pfizer shares boosted as it advances development of GLP weight loss pill
Novo Nordisk and Eli Lilly fell as Roche made weight loss breakthrough
GSK investors vexed as vax sales dented otherwise strong quarter
Novo Nordisk hit as revenue and profit growth failed to meet high expectations
Eli Lilly shares boosted as financials beat forecasts thanks to Mounjaro and Zepbound
Rocket Lab propelled higher by expectation beating financials
AstraZeneca’s UK vaccine hub under threat amid government funding rug-pull
Eli Lilly shares boosted by Mounjaro and Zepbound diabetes test results
More in AI
Remote work, not AI, may explain entry-level job losses
The data blamed on artificial intelligence largely disappears once economists factor in remote working. The widely held view that artificial intelligence (AI) is destroying entry-level jobs may be significantly overstated.